Ashish Kacholia Holds 1.84 Per Cent Stake; Leading Specialty Chemicals Stock Commissions 10.8 MW Solar Plant and Announces Plans for Additional 5 MW Expansion

The company's 1-year return is 117.59 per cent, while the 3-year return stands at 144.55 per cent.

Ami Organics Limited, a leading manufacturer of advanced pharmaceutical intermediates and specialty chemicals, has announced the full commissioning of its 10.8 MW solar power plant in Pratapnagar, Nandod, Narmada District, Gujarat. This development marks a significant step in the company's sustainability journey, aligning with its strategic goals to enhance energy independence and operational efficiency. The solar facility, comprising two captive plants of 5.4 MW each, is expected to deliver substantial cost savings by meeting the majority of the electricity needs for Ami Organics' Ankleshwar and Jhagadia units.

Mr. Naresh Patel, Chairman and Managing Director, emphasized the project's role in reducing dependence on conventional power sources and moving towards a cleaner energy portfolio. Additionally, the company is actively developing another 5 MW solar power plant to support its Sachin unit, further reinforcing its commitment to renewable energy. This initiative is part of Ami Organics' broader plan to establish a total solar power capacity of 15.80 MW, underscoring its dedication to reducing its carbon footprint and aligning with national net-zero goals.

Ami Organics Limited is a leading research and development-driven manufacturer specializing in specialty chemicals. The company focuses on advanced pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for new chemical entities, as well as materials for agrochemicals and fine chemicals. It has developed and commercialised over 520 products, serving more than 500 customers across 50 countries.

The company's business segments include Pharma Intermediates, which accounted for 76 per cent of revenue in 9MFY24, and Specialty Chemicals, which contributed 24 per cent. Ami Organics has significantly increased its export revenue share to 61 per cent in Q3 FY24, expanding its market presence to 55 countries. The company holds a substantial market share of 50 per cent to 90 per cent in key molecules and maintains strong relationships with top clients like Sun Pharma and Bayer. With three manufacturing facilities in Gujarat and a focus on R&D, Ami Organics continues to innovate, recently entering the electrolyte business and expanding its CDMO operations. The company has also been recognised for its sustainability efforts, receiving a Gold Medal from EcoVadis.

As of April 3, 2025, Ami Organics Limited's stock is priced at Rs 2,507.5. The 52-week high is Rs 2,622.75, and the 52-week low is Rs 1,077. The current price is not within 2 per cent of its 52-week high or low. Ami Organics Limited has a market capitalisation of Rs 10,133 crore. The company's 1-year return is 117.59 per cent, while the 3-year return stands at 144.55 per cent. The price-earnings (PE) ratio is 83.8. Major public shareholders include Dhwani Girishkumar Chovatia with 3.35 per cent, Ashish Kacholia with 1.84 per cent, and Vanaja Sundar Iyer with 1.16 per cent.

In the last one year, the stock price of the company has given multibagger returns of 121 per cent. Investors must keep this Small-Cap stock on their radar.

Disclaimer: The article is for informational purposes only and not investment advice.